|
Pronunciation |
|
(KOL
la je
nase) |
|
|
U.S. Brand
Names |
|
Biozyme-C®;
Santyl® |
|
|
Generic
Available |
|
No |
|
|
Pharmacological Index |
|
Enzyme, Topical Debridement |
|
|
Use |
|
Promotes debridement of necrotic tissue in dermal ulcers and severe
burns |
|
|
Pregnancy Risk
Factor |
|
C |
|
|
Contraindications |
|
Known hypersensitivity to collagenase |
|
|
Warnings/Precautions |
|
For external use only; avoid contact with eyes; monitor debilitated patients
for systemic bacterial infections because debriding enzymes may increase the
risk of bacteremia |
|
|
Adverse
Reactions |
|
1% to 10%: Local: Irritation
<1%: Pain and burning may occur at site of application
|
|
|
Overdosage/Toxicology |
|
Action of enzyme may be stopped by applying Burow's
solution |
|
|
Drug
Interactions |
|
Decreased effect: Enzymatic activity is inhibited by detergents, benzalkonium
chloride, hexachlorophene, nitrofurazone, tincture of iodine, and heavy metal
ions (silver and mercury) |
|
|
Mechanism of
Action |
|
Collagenase is an enzyme derived from the fermentation of Clostridium
histolyticum and differs from other proteolytic enzymes in that its
enzymatic action has a high specificity for native and denatured collagen.
Collagenase will not attack collagen in healthy tissue or newly formed
granulation tissue. In addition, it does not act on fat, fibrin, keratin, or
muscle. |
|
|
Usual Dosage |
|
Topical: Apply once daily (or more frequently if the dressing becomes
soiled) |
|
|
Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
No information available to require special precautions |
|
|
Dental Health:
Effects on Dental Treatment |
|
No effects or complications reported |
|
|
Patient
Information |
|
Use exactly as directed; do not overuse. Wear gloves to apply a thin film to
affected area. If dressing is necessary, use a porous dressing. Avoid contact
with eyes. Report increased swelling, redness, rash, itching, signs of
infection, worsening of condition, or lack of healing.
Pregnancy/breast-feeding precautions: Inform prescriber if you are or intend
to be pregnant. Consult prescriber if breast-feeding. |
|
|
Nursing
Implications |
|
Do not introduce into major body cavities; monitor debilitated patients for
systemic bacterial infections |
|
|
Dosage Forms |
|
Ointment, topical: 250 units/g (15 g, 30 g) |
|
|
References |
|
Chamberlain TM, Cali TS, Cuzzell J, et al,
"Assessment and Management of Pressure Sores in Long-Term Care Facilities,"
Consult Pharm, 1992, 7(12)1328-40.
|
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
|